Premium
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-05-26 | Ms. Xiangwei GongExec. VP of Strategic Group Development & President of Aptar Asia | -4,20k | 487,76k | Vente | 116,13 | 11,42k | -26,90% |
| 2026-05-21 | Mr. Hedi TliliPresident of Aptar Closures | -688,00 | 80,15k | Sale to Issuer | 116,50 | 24,23k | -2,76% |
| 2026-05-07 | Ms. Irene HudsonExec. VP, Chief Legal Officer & Corporate Secretary | -422,00 | 52,07k | Vente | 123,38 | 1,48k | -22,19% |
| 2026-05-07 | Ms. Irene HudsonExec. VP, Chief Legal Officer & Corporate Secretary | -842,00 | 10,16k | Derivative Exercise and Sale | 111,38 - 123,45 | 1,48k | - |
| 2026-05-01 | Mr. Hedi TliliPresident of Aptar Closures | -3,60k | 457,70k | Sale to Issuer | 127,21 | 24,92k | -12,62% |
| 2026-05-01 | Ms. Xiangwei GongExec. VP of Strategic Group Development & President of Aptar Asia | -2,56k | 304,57k | Sale to Issuer | 119,02 | 15,62k | -14,08% |
| 2026-05-01 | Mr. Gael TouyaPresident of Aptar Pharma | -4,18k | 531,10k | Sale to Issuer | 127,21 | 32,84k | -11,28% |
| 2026-05-01 | Ms. Irene HudsonExec. VP, Chief Legal Officer & Corporate Secretary | -247,00 | 29,40k | Sale to Issuer | 119,02 | 1,90k | -11,49% |
| 2026-05-01 | Ms. Shiela Pallerne VinczellerChief HR Officer | -2,15k | 255,89k | Sale to Issuer | 119,02 | 30,63k | -6,56% |
| 2026-05-01 | Mr. Stephan B. TandaPresident, CEO & Executive Director | -15,54k | 1,85M | Sale to Issuer | 119,02 | 241,87k | -6,04% |
| 2026-03-17 | Mr. Hedi TliliPresident of Aptar Closures | -273,00 | 35,48k | Sale to Issuer | 129,97 | 8,36k | -3,16% |
| 2026-03-17 | Mr. Gael TouyaPresident of Aptar Pharma | -320,00 | 41,59k | Sale to Issuer | 129,97 | 27,29k | -1,16% |
| 2026-03-17 | Ms. Mahawa Vanessa TourayInitié | -368,00 | 47,66k | Sale to Issuer | 129,50 | 9,35k | -3,79% |
| 2026-03-17 | Ms. Xiangwei GongExec. VP of Strategic Group Development & President of Aptar Asia | -213,00 | 27,58k | Sale to Issuer | 129,50 | 9,74k | -2,14% |
| 2026-03-17 | Ms. Irene HudsonExec. VP, Chief Legal Officer & Corporate Secretary | -37,00 | 4,79k | Sale to Issuer | 129,50 | 689,00 | -5,10% |
| 2026-03-17 | Ms. Shiela Pallerne VinczellerChief HR Officer | -139,00 | 18,00k | Sale to Issuer | 129,50 | 25,06k | -0,55% |
| 2026-03-17 | Mr. Stephan B. TandaPresident, CEO & Executive Director | -1,77k | 229,47k | Sale to Issuer | 129,50 | 204,12k | -0,86% |
| 2026-03-16 | Mr. Gael TouyaPresident of Aptar Pharma | -791,00 | 102,42k | Sale to Issuer | 129,48 | 27,61k | -2,78% |
| 2026-03-16 | Mr. Hedi TliliPresident of Aptar Closures | -677,00 | 87,66k | Sale to Issuer | 129,48 | 8,64k | -7,27% |
| 2026-03-15 | Mr. Stephan B. TandaPresident, CEO & Executive Director | -3,46k | 444,49k | Sale to Issuer | 128,65 | 205,90k | -1,65% |
| 2026-03-15 | Ms. Shiela Pallerne VinczellerChief HR Officer | -333,00 | 42,84k | Sale to Issuer | 128,65 | 25,20k | -1,30% |
| 2026-03-15 | Ms. Xiangwei GongExec. VP of Strategic Group Development & President of Aptar Asia | -481,00 | 61,88k | Sale to Issuer | 128,65 | 9,96k | -4,61% |
| 2026-03-15 | Ms. Irene HudsonExec. VP, Chief Legal Officer & Corporate Secretary | -72,00 | 9,26k | Sale to Issuer | 128,65 | 726,00 | -9,02% |
| 2026-03-02 | Mr. Gael TouyaPresident of Aptar Pharma | -335,00 | 47,91k | Sale to Issuer | 143,00 | 28,41k | -1,17% |
| 2026-02-27 | Mr. Hedi TliliPresident of Aptar Closures | -66,00 | 9,34k | Sale to Issuer | 141,53 | 9,31k | -0,70% |
| 2026-02-27 | Mr. Gael TouyaPresident of Aptar Pharma | -348,00 | 49,25k | Sale to Issuer | 141,53 | 28,74k | -1,20% |
| 2026-02-25 | Ms. Shiela Pallerne VinczellerChief HR Officer | -96,00 | 13,70k | Sale to Issuer | 142,68 | 25,53k | -0,37% |
| 2026-02-25 | Mr. Stephan B. TandaPresident, CEO & Executive Director | -940,00 | 134,12k | Sale to Issuer | 142,68 | 209,35k | -0,45% |
| 2026-02-24 | Ms. Xiangwei GongExec. VP of Strategic Group Development & President of Aptar Asia | -291,00 | 41,94k | Sale to Issuer | 144,14 | 10,37k | -2,73% |
| 2026-02-24 | Ms. Shiela Pallerne VinczellerChief HR Officer | -219,00 | 31,57k | Sale to Issuer | 144,14 | 24,75k | -0,88% |
| 2026-02-24 | Mr. Stephan B. TandaPresident, CEO & Executive Director | -1,32k | 190,41k | Sale to Issuer | 144,14 | 205,81k | -0,64% |
| 2026-02-23 | Ms. Xiangwei GongExec. VP of Strategic Group Development & President of Aptar Asia | -180,00 | 26,23k | Sale to Issuer | 145,72 | 10,66k | -1,66% |
| 2026-02-23 | Ms. Shiela Pallerne VinczellerChief HR Officer | -168,00 | 24,48k | Sale to Issuer | 145,72 | 24,97k | -0,67% |
| 2026-02-23 | Mr. Stephan B. TandaPresident, CEO & Executive Director | -987,00 | 143,83k | Sale to Issuer | 145,72 | 207,13k | -0,47% |
| 2026-02-18 | Mr. Gael TouyaPresident of Aptar Pharma | -3,50k | 494,74k | Vente | 141,35 | 27,96k | -11,12% |
| 2026-02-10 | Mr. Marc PrieurPresident of Aptar Beauty | -2,00k | 275,62k | Vente | 137,81 | 13,75k | -12,70% |
| 2025-12-12 | Mr. Daniel Richard AckermanSenior VP, Principal Accounting Officer & CAO | -15,00k | 751,64k | Derivative Exercise and Sale | 71,12 - 121,23 | 29,61k | - |
| 2025-09-11 | Mr. Gael TouyaPresident of Aptar Pharma | -2,50k | 340,30k | Vente | 136,05 - 136,13 | 31,46k | -7,36% |
| 2025-09-05 | Ms. Shiela Pallerne VinczellerChief HR Officer | -1,17k | 161,01k | Vente | 137,97 | 25,13k | -4,44% |
| 2025-06-13 | Mr. Marc PrieurPresident of Aptar Beauty | -2,00k | 305,61k | Vente | 152,80 | 15,75k | -11,27% |
| 2025-06-10 | Ms. Kimberly Y. ChaineyInitié | -1,67k | 255,32k | Vente | 152,79 | 11,09k | -13,10% |
| 2025-06-06 | Mr. Gael TouyaPresident of Aptar Pharma | -3,30k | 503,65k | Vente | 152,50 - 153,88 | 33,96k | -8,86% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
